Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
THE IMPACT OF CYSTOID MACULOPATHY IN USH2A RETINITIS PIGMENTOSA : A Retrospective 5-year Analysis
Alessandro Arrigo1,2, Emanuela Aragona1, Alessio Antropoli1
1Ophthalmology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy ; and.
Cystoid maculopathy (CM) in retinitis pigmentosa (RP) does not negatively impact long-term vision. This study found similar visual acuity and ellipsoid zone loss rates in RP eyes with and without CM over five years.
Area of Science:
- Ophthalmology
- Genetics
- Retinal Diseases
Background:
- Retinitis pigmentosa (RP) is a group of inherited retinal diseases.
- Cystoid maculopathy (CM) frequently complicates RP, but its long-term impact remains unclear.
- USH2A gene mutations are a common cause of RP.
Purpose of the Study:
- To describe the five-year outcome of eyes with USH2A-associated RP, comparing those with and without cystoid maculopathy (CM).
- To assess the clinical impact of CM on visual acuity and ellipsoid zone (EZ) loss in RP patients.
Main Methods:
- Retrospective analysis of USH2A-associated RP patients.
- Collected data on best corrected visual acuity (BCVA), ellipsoid zone (EZ) loss rate, and CM behavior over five years.
- Compared outcomes between eyes with and without CM, including treatment-naïve eyes with CM.
Main Results:
- No significant difference in visual acuity or EZ loss rate between RP eyes with and without CM over five years.
- Eyes with persistent CM showed slightly worse visual acuity.
- EZ loss rate accelerated during CM regression but returned to previous trends afterward.
- CM regression, recurrence, or persistence did not significantly impact BCVA or EZ loss rate.
Conclusions:
- Cystoid maculopathy (CM) does not appear to have a negative long-term impact on visual outcomes in USH2A-associated retinitis pigmentosa (RP).
- The presence and behavior of CM did not significantly alter the progression of visual acuity loss or ellipsoid zone loss in this cohort.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023